Menu
Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 13
Conventional and Novel Treatment Modalities in Rosacea
Authors Engin B, Özkoca D, Kutlubay Z, Serdaroğlu S
Received 8 March 2019
Accepted for publication 13 February 2020
Published 20 February 2020 Volume 2020:13 Pages 179—186
DOI https://doi.org/10.2147/CCID.S194074
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Jeffrey Weinberg
Burhan Engin, Defne Özkoca, Zekayi Kutlubay, Server Serdaroğlu
Istanbul University-Cerrahpaşa, Cerrahpaşa Medical Faculty, Department of Dermatology and Venerology, İstanbul, Turkey
Correspondence: Burhan Engin
Istanbul University-Cerrahpaşa, Cerrahpaşa Medical Faculty, Department of Dermatology and Venerology, İstanbul 34098, Turkey
Email burhanengin2000@yahoo.com
Abstract: Rosacea is a common skin disease that is troublesome for both the patients and the dermatologists. Erythema, telengiectasia, papulopustular changes and phymatous changes are the main problems faced by the patients and dermatologists in everyday practice. Due to the chronic and relapsing nature of the disease, patients are usually unsatisfied with conventional treatment methods. This article aims at redefining rosacea according to the 2017 consensus and reviewing the different treatment modalities for different manifestations of the disease in depth.
Keywords: new, resistant, rosacea, treatment
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.